N-Acetyl-L-leucyl-L-leucyl-L-methional
N-Acetyl-L-leucyl-L-leucyl-L-methional is a Calpain II inhibitor with an IC50 of 0.24 μM against porcine Calpain II. N-Acetyl-L-leucyl-L-leucyl-L-methional forms a stable tetrahedral adduct with the thiol group at the active site of Calpain II, thereby inhibiting proteolytic activity. N-Acetyl-L-leucyl-L-leucyl-L-methionally inhibits cathepsins in a non-selective manner. N-Acetyl-L-leucyl-L-leucyl-L-methional reduces SARS-CoV-2 infection levels in human coronary artery endothelial cells in vitro. N-Acetyl-L-leucyl-L-leucyl-L-methional can be used in research related to cataracts and coronavirus infections.
For research use only. We do not sell to patients.
- CAS No.: 145757-50-2
- Formula: C18H33N3O4S
- Molecular Weight:387.54
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
Calpain II 0.24 μM (IC50) |
In Vitro
N-Acetyl-L-leucyl-L-leucyl-L-methional inhibits purified porcine heart calpain II with an IC50 value of 0.24 μM[1].
N-Acetyl-L-leucyl-L-leucyl-L-methional (200 μM; pre-incubated for 12 h prior to treatment with Calcimycin (HY-N6687); detected after 5 d of culture) does not significantly reduce A23187-induced nuclear opacity in isolated lenses from 4.5-week-old Sprague-Dawley rats, and instead induces diffuse lens opacity[1]
N-Acetyl-L-leucyl-L-leucyl-L-methional (70 μM; used in combination with 177 μM Calpain Inhibitor I; pre-treated for 30 min; co-incubated for 12-24 h) attenuates Prostaglandin E2 (HY-101952)-induced degradation of Ankyrin R in human red blood cells. It does not reduce PGE2-induced phosphatidylserine externalization at 24 h[2].
N-Acetyl-L-leucyl-L-leucyl-L-methional (1 µM; 3 days post-infection) significantly reduces the level of SARS-CoV-2 spike protein in human coronary artery endothelial cells (HCAEC)[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Human erythrocytes from healthy volunteers
-
Concentration:ALLM, 70 μM, Calpain Inhibitor I, 177 μM, Prostaglandin E2, 50 μM
-
Incubation Time:30 min pretreatment followed by 12 h co-incubation
-
Result:Attenuated Prostaglandin E2-induced ankyrin R degradation when combined with Calpain Inhibitor I.
Chemical Information
-
CAS No. 145757-50-2
-
Molecular Weight 387.54
-
Formula C18H33N3O4S
-
SMILES
CC(C)C[C@@H](C(N)=O)N(C([C@H](CC(C)C)NC(C)=O)=O)[C@H](C=O)CCS
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Endothelial Tube Formation Assay
Endothelial tube formation assay evaluates the ability of endothelial cells to attach, migrate, align, and organize into capillary-like networks when cultured on gelled basement membrane extract or Matrigel; the readout is the morphology and quantity of tube-like networks, which reflects an in vitro endothelial morphogenesis step related to angiogenesis. Basement membrane extract/Matrigel provides laminin-rich extracellular matrix cues that support endothelial differentiation into capillary-like structures, but it can contain biologically active growth factors, so growth-factor-reduced matrix is preferred when testing defined angiogenic stimulators or inhibitors.
Purity & Documentation
References
[1]. Lampi KJ, et al. Comparison of Cell-Permeable Calpain Inhibitors and E64 in Reduction of Cataract in Cultured Rat Lenses. Toxicol Appl Pharmacol. 1992;117:53-57. [Content Brief]
[2]. Lang PA, et al. PGE(2) in the regulation of programmed erythrocyte death. Cell death and differentiation. 2005 May;12(5):415-28. [Content Brief]
[3]. Wagner JUG, et al. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic research in cardiology. 2021 Jul 05;116(1):42. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)